Ikena Oncology Inc
NASDAQ:IKNA
Income Statement
Earnings Waterfall
Ikena Oncology Inc
Revenue
|
9.2m
USD
|
Operating Expenses
|
-84.6m
USD
|
Operating Income
|
-75.4m
USD
|
Other Expenses
|
7.3m
USD
|
Net Income
|
-68.2m
USD
|
Income Statement
Ikena Oncology Inc
Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||
Revenue |
7
N/A
|
7
+7%
|
11
+53%
|
31
+186%
|
31
0%
|
28
-10%
|
30
+10%
|
16
-49%
|
18
+12%
|
19
+9%
|
14
-27%
|
9
-34%
|
|
Operating Income | |||||||||||||
Operating Expenses |
(47)
|
(56)
|
(74)
|
(65)
|
(72)
|
(77)
|
(83)
|
(87)
|
(87)
|
(86)
|
(83)
|
(85)
|
|
Selling, General & Administrative |
(8)
|
(11)
|
(16)
|
(18)
|
(21)
|
(22)
|
(22)
|
(22)
|
(21)
|
(21)
|
(22)
|
(25)
|
|
Research & Development |
(40)
|
(45)
|
(58)
|
(47)
|
(51)
|
(56)
|
(61)
|
(64)
|
(66)
|
(65)
|
(61)
|
(60)
|
|
Operating Income |
(41)
N/A
|
(48)
-19%
|
(63)
-30%
|
(34)
+46%
|
(41)
-21%
|
(50)
-20%
|
(53)
-7%
|
(71)
-34%
|
(69)
+2%
|
(67)
+4%
|
(69)
-2%
|
(75)
-10%
|
|
Pre-Tax Income | |||||||||||||
Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
3
|
4
|
5
|
7
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
1
|
1
|
1
|
(0)
|
|
Pre-Tax Income |
(41)
N/A
|
(48)
-19%
|
(63)
-30%
|
(34)
+46%
|
(41)
-21%
|
(49)
-19%
|
(52)
-6%
|
(69)
-33%
|
(66)
+4%
|
(63)
+5%
|
(63)
N/A
|
(68)
-9%
|
|
Net Income | |||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(41)
|
(48)
|
(63)
|
(34)
|
(41)
|
(49)
|
(52)
|
(69)
|
(66)
|
(63)
|
(63)
|
(68)
|
|
Net Income (Common) |
(41)
N/A
|
(48)
-19%
|
(63)
-30%
|
(34)
+46%
|
(41)
-21%
|
(49)
-19%
|
(52)
-6%
|
(69)
-33%
|
(66)
+4%
|
(63)
+5%
|
(63)
N/A
|
(68)
-9%
|
|
EPS (Diluted) |
-1.13
N/A
|
-1.37
-21%
|
-1.77
-29%
|
-0.95
+46%
|
-1.14
-20%
|
-1.36
-19%
|
-1.44
-6%
|
-1.9
-32%
|
-1.83
+4%
|
-1.59
+13%
|
-1.44
+9%
|
-1.63
-13%
|